id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
CMS-2009-0066-0001,CMS,CMS-2009-0066,Medicare Advantage and Prescription Drug Program: Final Marketing Provisions CFR 422.111(a)(3) and 423.128 (a)(3)-(CMS-10260),Notice,,2009-07-17T04:00:00Z,2009,7,2009-07-17T04:00:00Z,2009-09-16T03:59:59Z,2009-07-24T21:32:05Z,E9-17079,0,0,09000064809f3e29